Description
The National Cancer Institute (NCI) is soliciting grant applications for exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. The emphasis is on supporting the development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology.
• The proposed technologies must be focused on improving molecular and/or cellular characterizations of cancer biology.
• The technologies should have the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, or epidemiology.
• The program aims to address issues associated with cancer health disparities.
• The grant is part of the NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.